Corvus Pharmaceuticals Inc. (CRVS) Declined -5.62% or -0.25 To Price $4.2 On Thursday


Corvus Pharmaceuticals Inc. (CRVS) declined -5.62% or -0.25 to $4.2. It is approximately 99668 shares traded, which is 72.19% compare to the average total volume 138069. The market cap of CRVS is $122.98 million. The year to date change is -1.4%. The 52 week price range is from $3.22 to $13.91. Price of CRVS have changed 11.53% during last week. It have changed -2.20% over last month, -41.22% over last 3 months, -52.15% over last 6 months and -45.40% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRVS is 4.71. It is 12.14% above current price. The 200-day Moving Averages for CRVS is 8.63. It is 105.48% above current price. The 52-week High is 13.91. It is 231.19% from the current price. The 52-week Low is 3.22. It is -23.33% from current price.

There are some statistics of CRVS. It is has market cap $122.98 million. The share outstanding is 29.28 million. The average volume is 138069. The percent of top 15 Institution holding is 104.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRVS is -45.70%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRVS is -41.88%.


Tags:

Share this post